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Abstract Phosphorylation of the pyruvate dehydrogenase com- 
ponent (El) of the muscle pyrnvate dehydrogenase complex 
(PDC) by El-kinase inhibits substrate conversion both in oxida- 
tive and non-oxidative reactions. Circular dichroism spectra were 
used to monitor the effect of phosphorylation on the following 
stages of the process: holoform formation from apo-E1 and thia- 
mine pyrophosphate (TPP), substrate binding and active site de- 
acetylation. It has been shown that phosphorylation of E1 reduces 
its affinity for TPP and prevents holo-E1 interaction with py- 
ruvate. Phosphorylated and dephosphorylated PDC convert 2- 
hydroxyethyl-TPP in similar ways involving half of their active 
sites; all active sites of E1 function in the presence of deacetyl- 
ating agents. The data obtained suggest hat the pbosphorylation 
and substrate binding sites interact with each other. 
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2. Experimental 
PDC was isolated from pigeon breast muscle according to Jagan- 
nathan and Schweet [10], with some modifications. The PDC activity 
was estimated from the rate of NADH production in the presence of
CoA [11]. E 1 activity was determined with an artificial electron acceptor 
(2,6-dichlorophenolindophenol) as described previously [12]. Pyruvate 
consumption due to non-oxidative action of PDC was measured as 
follows: PDC (native or phosphorylated by endogenous E l-kinase with 
ATP) was incubated in the presence ofexcess TPP and pyruvate. Ali- 
quotes were taken in time and the residual level of the substrate was 
determined from NADH decrease inthe presence oflactate dehydroge- 
nase. El-kinase was assayed by following PDC inactivation i  the 
presence ofATE The incubation medium contained 0.1 M potassium 
phosphate buffer, pH 7.0, 0.5-2 mg/ml PDC, 0.1 M MgC12 and varied 
amounts of ATE Aliquots were withdrawn to be assayed for the en- 
zyme activity. Circular dichroism (CD) spectra were recorded on a 
CNRS-Russel-Jouan Dichrograph 111 as described earlier [7,9]. The 
data obtained were expressed in the form of the ratio Ae/c, where Ae 
is the differential dichroic absorbance, expressed in optical scale units; 
c is the protein concentration i  mg/ml. Acetoin was assayed by the 
method of Westerfeld [13]. 
1. Introduction 
The pyruvate dehydrogenase complex (PDC), turning py- 
ruvate to acetyl CoA, is crucial to metabolism since it catalyzes 
an irreversible r action at the junction of the glycolytic pathway 
with the Krebs cycle. PDC from eucaryotes comprises three 
catalytic omponents (El, E2, and E3) as well as component 
X essential to the E2 E3 interaction [1,2]. The E1 component 
catalyzes the rate-limiting reaction, namely, thiamine pyro- 
phosphate (TPP)-dependent decarboxylation f pyruvate to 
produce 2-hydroxyethyl-TPP (HETPP) and reductive acetyla- 
tion of lipoic acid residues covalently bound to E2. Two regu- 
latory enzymes, kinase and phosphatase, phosphorylate-de- 
phosphorylate El, thereby inactivating-reactivating the whole 
complex [1]. Three serine residues in the ~ subunit oftetrameric 
E1 molecule (~fl)2 have been shown to undergo modification, 
and their role and relative contribution tothe inactivation proc- 
ess have been examined. E1 has been shown to be completely 
inactivated by phosphorylation f only one site per enzyme 
molecule [3 5]. The mechanism by which phosphoserine r si- 
due formation inhibits the catalytic activity of E1 is not clear. 
It is believed that the modification of the enzyme by phospho- 
rylation blocks HETPP-producing reactions [6]. 
In this work the effect of regulatory phosphorylation on 
holoenzyme complex formation, substrate binding and active 
center deacetylation was studied using spectral measurements 
[7,9]. It has been shown that E1 phosphorylation, which de- 
creases its affinity for TPP, does not preclude holo-E1 forma- 
tion but inhibits its interaction with pyruvate. 
*Corresponding author. Fax: (9) (01 l) 7095 939 3181. 
3. Results 
Fig. IA shows the time course of the El-kinase action on the 
pyruvate: NAD oxidoreductase activity of PDC in the presence 
of different concentrations of ATE Changes in the E1 activity 
measured with an artificial electron acceptor were similar (not 
shown). Besides its oxidative function, PDC catalyzes TPP- 
dependent non-oxidative side reactions to produce acetalde- 
hyde and products of acyloin condensation [10,14]. The time 
course of pyruvate consumption by PDC in the absence of CoA 
and NAD is shown in Fig. 1B (curve 1). PDC activity is de- 
creased at increasing ATP concentration (curves 2-5). The ef- 
fect of ATP on the amount of acetoin produced by PDC is 
shown in Fig. 1C. This reaction is also inhibited by E l-kinase. 
Thus, modification of PDC by phosphorylation i hibits all 
modes of its activity requiring the action of the E 1 component. 
It was of interest in this connection to investigate he effect 
of pyruvate on enzyme inactivation by phosphorylation. Fig. 
2 shows that enzyme inactivation is more substantial in the 
presence of pyruvate (compare curves 1 and 24).  Hydroxypy- 
ruvate, aconvertible substrate analog, produces a similar effect, 
whereas pyruvamide (a decarboxylation-resistant competitive 
inhibitor and an allosteric activator of PDC [11]) partially pro- 
tects the enzyme from inactivation by phosphorylation (curve 5). 
The effect of phosphorylation  different steps of the E1 
action was studied by spectral analysis. We have shown earlier 
that a tryptophan residue of apo-El forms a charge transfer 
complex (CTC) with TPP during holo-E1 reconstruction. This 
is well reflected by a negative CD spectral Cotton effect with 
a maximum at 330 nm [7-9]. Fig. 3 shows that the spectral 
characteristics of PDC saturated with TPP are similar to those 
of the isolated E1 [9]. 
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Fig. 1. The effect of ATP on the time course of PDC activity assayed 
by the rate of NADH generation (A), non-oxidative pyruvate consump- 
tion (B), and acetoin production (C). Conditions: (A) 0.6 mg/ml PDC, 
0.05 (1), 0.1 (2) or 0.44 (3) mM ATP; (B) 1.53 mg/ml PDC, 0 (1), 0.04 
(2), 0.05 (3), 0.4 (4) or 1.92 (5) mM ATP; (C) 2.83 mg/ml PDC, 0.29 
(1) or 4.6 (2) mM ATE 
Addition of pyruvate to the holoform leads to a decrease in 
the CTC band intensity until its full diappearance (Fig. 4A). 
The effect of pyruvate on the protein spectrum can be explained 
by disturbance of the electronic interaction i the dono-accep- 
tor pair, the indolyl group of tryptophan and the thiazol ring 
of TPP, due to substrate binding to the 2-carbanion of TPP. 
Fig. 4B (curve 1) shows changes in the CTC spectral band 
intensity at 330 nm on addition of TPP to the phospho-PDC 
with the residual activity of 8%. It is apparent that protein 
phosphorylation does not prevent CTC formation, but satura- 
tion of phospho-PDC with the coenzyme requires one order of 
magnitude higher concentrations of TPP. These data show that 
PDC phosphorylation byendogenous El-kinase does not pre- 
vent TPP binding to the active sites of phospho-E1, but de- 
creases the strength of the interaction. Fig. 4B (curve 2) shows 
that the spectral amplitude due to CTC for phospho-PDC-TPP 
is not affected by pyruvate, suggesting that the substrate is not 
bound to the active sites of phosphorylated holo-E1. 
The interaction of E1 (whether isolated or within PDC) with 
HETPP reveals the half-of-the-sites reactivity [15]. Fig. 4C, 
(curve l) shows that the phosphorylated PDC also uses only 
half of its active sites to interact with the HETPP. The ampli- 
tude of the CTC band increases twofold upon addition of CoA 
(curve 2) or DTT (not shown). When the deacetylating reagent 
and HETPP are added to the apoenzyme simultaneously, the 
amplitude of the CTC band in the spectra is indicative of the 
holoform formation at both active sites of E1 (curve 3). 
4. Discussion 
The regulation of muscle PDC by means of phosphoryla- 
tion dephosphorylation of the c~ subunit of E1 was described 
earlier [8]. Kinetic investigations show that phosphorylation 
inhibits pyruvate conversion both in oxidative and non-oxida- 
tive reactions (Fig. 1). This means that the formation of 
phosphoserine in the El blocks an early step of enzyme cataly- 
sis. 
Spectral studies howed that phosphorylation f PDC does 
not prevent the formation of the 'correct' holo-E1, but changes 
the spectral effect caused by its interaction with pyruvate. This 
suggests that phosphorylation f E1 prevents substrate binding 
to the active site. These results are consistent with the data 
reported earlier [6] in that phosphorylation f PDC influences 
the formation of HETPP via the mainstream reaction. How- 
ever, the spectral analysis used to detect separate stages of the 
enzyme action allowed one to identify holo-E1 substrate ad- 
duct formation as the step blocked by phosphorylation. 
E1 tetramer (~fl)2 has been found to be a functional dimer 
exhibiting cooperativity during its interaction with HETPP 
[15]. According to the mechanism proposed, HETPP undergoes 
oxidative conversion to form an acetylthioenzyme with 
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Fig. 2. The effects of pyruvate and its analogs on PDC (0.33 mg/ml) 
inactivation by endogenous E 1-kinase in the presence of0.19 mM ATE 
Additions: m, none; e, D, A, 0.25, 0.37 and 0.61 mM pyruvate, respec- 
tively; A, 3.9 mM hydroxypyruvate; o, 1.5 mM pyruvamide. 
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free TPP at the active site. Enzyme acetylation-deacetyla- 
tion is presumed to be a rate-limiting step in cooperative catal- 
ysis [15]. 
We have shown that phospho-PDC can interact with HETPP 
to form CTC only in half of the active sites (Fig. 4C). All active 
sites of phospho-El become involved in HETPP conversion 
only after being deacetylated in the presence of CoA or DTT. 
Similar esults have been reported earlier for dephospho-E 1 [9]. 
This means that: (i) El phosphorylation does not preclude 
its ability to convert he already formed HETPP to produce 
the acetylated enzyme with free TPP at the active site; 
(ii) phosphoserine formation in the regulatory site does not 
affect subunit interactions ensuring the cooperativity of 
HETPP conversion by functional dimers of E1 within PDC. 
In view of the dependency of the holoenzyme-pyruvate in r- 
actions on phosphorylation, it was of interest o examine the 
reverse relationship: how pyruvate affects the rate of E1 inacti- 
vation by kinase. We show here that pyruvate in the concentra- 
tions used does not prevent phosphorylation, rather, it stimu- 
lates kinase. Hydroxypyruvate, when used as a substrate, pro- 
duced a similar effect, in contrast to pyruvamide, which bears 
no carboxylic group and hence cannot be converted by PDC. 
The stimulating effect of pyruvate on the El-kinase seems to 
be indirect and related to the formation of acetyldihydrolipoate 
residues, effective accelerators of kinase reactions [5]. The pro- 
tective ffect of pyruvamide, which displays an affinity for E1 
similar to that of the substrate and simulates holoenzyme-sub- 
strate complex formation, suggests that the substrate is effec- 
tive, when bound. The partial protection from phosphorylation 
(inactivation) of the enzyme provided by this analog does not 
rule out that the phosphorylation a d substrate binding sites 
are close to each other. Competition for the positively charged 
guanidinium group of the arginine residue, which binds the 
pyruvate carboxylate [16], may block substrate binding to the 
active sites of phosphorylated El. 
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Fig. 3. TPP-induced changes in the CD spectra of PDC. (1), baseline; 
PDC, 2 mg/ml in the absence (2) and in the presence (3) of 10.2tiM TPP. 
The difference spectrum is shown in the inset. 
0 2 4 6 0 2000 800 [LI.10~M 
zXS.o/[PDE] I I 
1 ! 2 
10" • ~ T ~ i, 
s L 
'1 
a i i r i R - -  i i i I - 
5 10 50 100 0 100 1000 3000 
[L ] / [PDE]  
/,GJ[PBC] ~ 3 
10 L 
5 1 
4 8 50 100 [LI.10]M 
Fig. 4. The effects of various ligands (L) on the intensity of the CTC 
band of PDC (1.87 mg/ml). A, dephospho-PDC, and B, pbospho-PDC 
after interactions with TPP (1), pyruvate (2) or CoA (3) added consec- 
utively; C, phospho-PDC with added HETPP (1), CoA (1 mM) added 
after HETPP (2), HETPP added to phospho-PDC plus 1 mM CoA (3). 
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